| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Antigen Presentation After Stroke
|
Miró-Mur, Francesc
|
|
2016
|
13 |
4 |
p. 719-728
|
artikel
|
| 2 |
Antigen Presentation After Stroke
|
Miró-Mur, Francesc
|
|
|
13 |
4 |
p. 719-728
|
artikel
|
| 3 |
Astrocytes: Integrative Regulators of Neuroinflammation in Stroke and Other Neurological Diseases
|
Cekanaviciute, Egle
|
|
2016
|
13 |
4 |
p. 685-701
|
artikel
|
| 4 |
Astrocytes: Integrative Regulators of Neuroinflammation in Stroke and Other Neurological Diseases
|
Cekanaviciute, Egle
|
|
|
13 |
4 |
p. 685-701
|
artikel
|
| 5 |
B-Cell Depletion with CD20 Antibodies as New Approach in the Treatment of Inflammatory and Immunological Events Associated with Spinal Cord Injury
|
Casili, Giovanna
|
|
2016
|
13 |
4 |
p. 880-894
|
artikel
|
| 6 |
B-Cell Depletion with CD20 Antibodies as New Approach in the Treatment of Inflammatory and Immunological Events Associated with Spinal Cord Injury
|
Casili, Giovanna
|
|
|
13 |
4 |
p. 880-894
|
artikel
|
| 7 |
Blood/Brain Biomarkers of Inflammation After Stroke and Their Association With Outcome: From C-Reactive Protein to Damage-Associated Molecular Patterns
|
Bustamante, Alejandro
|
|
2016
|
13 |
4 |
p. 671-684
|
artikel
|
| 8 |
Blood/Brain Biomarkers of Inflammation After Stroke and Their Association With Outcome: From C-Reactive Protein to Damage-Associated Molecular Patterns
|
Bustamante, Alejandro
|
|
|
13 |
4 |
p. 671-684
|
artikel
|
| 9 |
CD206-Targeted Liposomal Myelin Basic Protein Peptides in Patients with Multiple Sclerosis Resistant to First-Line Disease-Modifying Therapies: A First-in-Human, Proof-of-Concept Dose-Escalation Study
|
Belogurov, Alexey
|
|
2016
|
13 |
4 |
p. 895-904
|
artikel
|
| 10 |
CD206-Targeted Liposomal Myelin Basic Protein Peptides in Patients with Multiple Sclerosis Resistant to First-Line Disease-Modifying Therapies: A First-in-Human, Proof-of-Concept Dose-Escalation Study
|
Belogurov Jr., Alexey
|
|
|
13 |
4 |
p. 895-904
|
artikel
|
| 11 |
Clinical Trials of Immunomodulation in Ischemic Stroke
|
Veltkamp, Roland
|
|
2016
|
13 |
4 |
p. 791-800
|
artikel
|
| 12 |
Clinical Trials of Immunomodulation in Ischemic Stroke
|
Veltkamp, Roland
|
|
|
13 |
4 |
p. 791-800
|
artikel
|
| 13 |
Combined Metabolomics and Transcriptomics Approaches to Assess the IL-6 Blockade as a Therapeutic of ALS: Deleterious Alteration of Lipid Metabolism
|
Patin, Franck
|
|
2016
|
13 |
4 |
p. 905-917
|
artikel
|
| 14 |
Combined Metabolomics and Transcriptomics Approaches to Assess the IL-6 Blockade as a Therapeutic of ALS: Deleterious Alteration of Lipid Metabolism
|
Patin, Franck
|
|
|
13 |
4 |
p. 905-917
|
artikel
|
| 15 |
Fingolimod: A Disease-Modifier Drug in a Mouse Model of Amyotrophic Lateral Sclerosis
|
Potenza, Rosa Luisa
|
|
2016
|
13 |
4 |
p. 918-927
|
artikel
|
| 16 |
Fingolimod: A Disease-Modifier Drug in a Mouse Model of Amyotrophic Lateral Sclerosis
|
Potenza, Rosa Luisa
|
|
|
13 |
4 |
p. 918-927
|
artikel
|
| 17 |
Heterogeneity of B Cell Functions in Stroke-Related Risk, Prevention, Injury, and Repair
|
Selvaraj, Uma Maheswari
|
|
2016
|
13 |
4 |
p. 729-747
|
artikel
|
| 18 |
Heterogeneity of B Cell Functions in Stroke-Related Risk, Prevention, Injury, and Repair
|
Selvaraj, Uma Maheswari
|
|
|
13 |
4 |
p. 729-747
|
artikel
|
| 19 |
Inflammation and Stroke: An Overview
|
Anrather, Josef
|
|
2016
|
13 |
4 |
p. 661-670
|
artikel
|
| 20 |
Inflammation and Stroke: An Overview
|
Anrather, Josef
|
|
|
13 |
4 |
p. 661-670
|
artikel
|
| 21 |
Inflammation and the Silent Sequelae of Stroke
|
Becker, Kyra J.
|
|
2016
|
13 |
4 |
p. 801-810
|
artikel
|
| 22 |
Inflammation and the Silent Sequelae of Stroke
|
Becker, Kyra J.
|
|
|
13 |
4 |
p. 801-810
|
artikel
|
| 23 |
Interleukin-6 Blockade as Rescue Therapy in Autoimmune Encephalitis
|
Dale, Russell C.
|
|
2016
|
13 |
4 |
p. 821-823
|
artikel
|
| 24 |
Interleukin-6 Blockade as Rescue Therapy in Autoimmune Encephalitis
|
Dale, Russell C.
|
|
|
13 |
4 |
p. 821-823
|
artikel
|
| 25 |
Is Immunomodulation a Principal Mechanism Underlying How Cell-Based Therapies Enhance Stroke Recovery?
|
Satani, Nikunj
|
|
2016
|
13 |
4 |
p. 775-782
|
artikel
|
| 26 |
Is Immunomodulation a Principal Mechanism Underlying How Cell-Based Therapies Enhance Stroke Recovery?
|
Satani, Nikunj
|
|
|
13 |
4 |
p. 775-782
|
artikel
|
| 27 |
Low-Affinity Neurotrophin Receptor p75 Promotes the Transduction of Targeted Lentiviral Vectors to Cholinergic Neurons of Rat Basal Forebrain
|
Antyborzec, Inga
|
|
2016
|
13 |
4 |
p. 859-870
|
artikel
|
| 28 |
Low-Affinity Neurotrophin Receptor p75 Promotes the Transduction of Targeted Lentiviral Vectors to Cholinergic Neurons of Rat Basal Forebrain
|
Antyborzec, Inga
|
|
|
13 |
4 |
p. 859-870
|
artikel
|
| 29 |
Microglia and Monocyte-Derived Macrophages in Stroke
|
Kim, Eunhee
|
|
2016
|
13 |
4 |
p. 702-718
|
artikel
|
| 30 |
Microglia and Monocyte-Derived Macrophages in Stroke
|
Kim, Eunhee
|
|
|
13 |
4 |
p. 702-718
|
artikel
|
| 31 |
Neuroimmune Response in Ischemic Preconditioning
|
McDonough, Ashley
|
|
2016
|
13 |
4 |
p. 748-761
|
artikel
|
| 32 |
Neuroimmune Response in Ischemic Preconditioning
|
McDonough, Ashley
|
|
|
13 |
4 |
p. 748-761
|
artikel
|
| 33 |
Neuroprotection by Epigenetic Modulation in a Transgenic Model of Multiple System Atrophy
|
Sturm, Edith
|
|
2016
|
13 |
4 |
p. 871-879
|
artikel
|
| 34 |
Neuroprotection by Epigenetic Modulation in a Transgenic Model of Multiple System Atrophy
|
Sturm, Edith
|
|
|
13 |
4 |
p. 871-879
|
artikel
|
| 35 |
Prophylactic Antibiotic Therapy for Preventing Poststroke Infection
|
Schwarz, Stefan
|
|
2016
|
13 |
4 |
p. 783-790
|
artikel
|
| 36 |
Prophylactic Antibiotic Therapy for Preventing Poststroke Infection
|
Schwarz, Stefan
|
|
|
13 |
4 |
p. 783-790
|
artikel
|
| 37 |
Regulation of Caveolin-1 and Junction Proteins by bFGF Contributes to the Integrity of Blood–Spinal Cord Barrier and Functional Recovery
|
Ye, Li-Bing
|
|
2016
|
13 |
4 |
p. 844-858
|
artikel
|
| 38 |
Regulation of Caveolin-1 and Junction Proteins by bFGF Contributes to the Integrity of Blood–Spinal Cord Barrier and Functional Recovery
|
Ye, Li-Bing
|
|
|
13 |
4 |
p. 844-858
|
artikel
|
| 39 |
Stroke, Inflammation and the Immune Response: Dawn of a New Era
|
Becker, Kyra J.
|
|
2016
|
13 |
4 |
p. 659-660
|
artikel
|
| 40 |
Stroke, Inflammation and the Immune Response: Dawn of a New Era
|
Becker, Kyra J.
|
|
|
13 |
4 |
p. 659-660
|
artikel
|
| 41 |
The Atypical Antipsychotic Paliperidone Regulates Endogenous Antioxidant/Anti-Inflammatory Pathways in Rat Models of Acute and Chronic Restraint Stress
|
MacDowell, Karina S.
|
|
2016
|
13 |
4 |
p. 833-843
|
artikel
|
| 42 |
The Atypical Antipsychotic Paliperidone Regulates Endogenous Antioxidant/Anti-Inflammatory Pathways in Rat Models of Acute and Chronic Restraint Stress
|
MacDowell, Karina S.
|
|
|
13 |
4 |
p. 833-843
|
artikel
|
| 43 |
The Gut Microbiome as Therapeutic Target in Central Nervous System Diseases: Implications for Stroke
|
Winek, Katarzyna
|
|
2016
|
13 |
4 |
p. 762-774
|
artikel
|
| 44 |
The Gut Microbiome as Therapeutic Target in Central Nervous System Diseases: Implications for Stroke
|
Winek, Katarzyna
|
|
|
13 |
4 |
p. 762-774
|
artikel
|
| 45 |
Tocilizumab in Autoimmune Encephalitis Refractory to Rituximab: An Institutional Cohort Study
|
Lee, Woo-Jin
|
|
2016
|
13 |
4 |
p. 824-832
|
artikel
|
| 46 |
Tocilizumab in Autoimmune Encephalitis Refractory to Rituximab: An Institutional Cohort Study
|
Lee, Woo-Jin
|
|
|
13 |
4 |
p. 824-832
|
artikel
|
| 47 |
Use of Antiepileptic Drugs During Pregnancy: Evolving Concepts
|
Pennell, Page B.
|
|
2016
|
13 |
4 |
p. 811-820
|
artikel
|
| 48 |
Use of Antiepileptic Drugs During Pregnancy: Evolving Concepts
|
Pennell, Page B.
|
|
|
13 |
4 |
p. 811-820
|
artikel
|
Tijdschrift beschrijving